The mechanisms by which general anesthetics have their clinically desired effects are not yet fully understood. The work proposed in this Program is designed to define the molecular target(s) for anesthetic steroids and to clarify the way in which action at these targets results in anesthesia. The underlying idea is that steroid anesthetics act at defined sites on proteins and, in particular, the proteins involved in information transfer between neurons. The proposed research will build on a series of advances made in preceding periods of the Program, which have provided insights into the sites and mechanisms of action for steroids. One objective of the Program is to define the structural basis for steroid interaction with a specific target, the GABA-A receptor. This work will involve complementary studies of the structure-activity relationship for steroid analogues and mutational studies of receptor structure coupled with identification of the residues labeled by site-specific photo-activated steroid analogues. The second objective of the Program is to clarify the mechanisms by which steroids have their actions on their molecular targets, including studies of functional effects on target proteins and examination of steroid access. The third objective is to examine the role of steroid partitioning among cellular membrane pools in determining the time course and magnitude of steroid action. The final objective is to correlate the pharmacological and physiological results with the production of anesthesia or other states defined only at the level of the whole animal. Although a major focus is on studies of the GABA-A receptor, comparative studies of glutamatergic, glycinergic and GABA-C receptors will be performed. Each project addresses one or another aspect of the action of anesthetic steroids at the cellular and molecular level. The Program as a whole will integrate these complementary studies and provide the resources for continued development of novel compounds and for assays of drug effects on behavioral states.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Research Program Projects (P01)
Project #
5P01GM047969-20
Application #
8118832
Study Section
Special Emphasis Panel (ZGM1-PPBC-5 (AN))
Program Officer
Cole, Alison E
Project Start
1992-08-01
Project End
2013-07-31
Budget Start
2011-08-01
Budget End
2013-07-31
Support Year
20
Fiscal Year
2011
Total Cost
$1,746,857
Indirect Cost
Name
Washington University
Department
Anesthesiology
Type
Schools of Medicine
DUNS #
068552207
City
Saint Louis
State
MO
Country
United States
Zip Code
63130
Budelier, Melissa M; Cheng, Wayland W L; Bergdoll, Lucie et al. (2017) Photoaffinity labeling with cholesterol analogues precisely maps a cholesterol-binding site in voltage-dependent anion channel-1. J Biol Chem 292:9294-9304
Jiang, Xiaoping; Shu, Hong-Jin; Krishnan, Kathiresan et al. (2016) A clickable neurosteroid photolabel reveals selective Golgi compartmentalization with preferential impact on proximal inhibition. Neuropharmacology 108:193-206
Zhou, Yu; Xia, Xiao-Ming; Lingle, Christopher J (2015) Cadmium-cysteine coordination in the BK inner pore region and its structural and functional implications. Proc Natl Acad Sci U S A 112:5237-42
Li, Ping; Akk, Gustav (2015) Synaptic-type ?1?2?2L GABAA receptors produce large persistent currents in the presence of ambient GABA and anesthetic drugs. Mol Pharmacol 87:776-81
Purgert, Carolyn A; Izumi, Yukitoshi; Jong, Yuh-Jiin I et al. (2014) Intracellular mGluR5 can mediate synaptic plasticity in the hippocampus. J Neurosci 34:4589-98
Bandari, Suman; Chakraborty, Hirak; Covey, Douglas F et al. (2014) Membrane dipole potential is sensitive to cholesterol stereospecificity: implications for receptor function. Chem Phys Lipids 184:25-9
Eaton, Megan M; Lim, You Bin; Covey, Douglas F et al. (2014) Modulation of the human ?1 GABAA receptor by inhibitory steroids. Psychopharmacology (Berl) 231:3467-78
Zolkowska, Dorota; Dhir, Ashish; Krishnan, Kathiresan et al. (2014) Anticonvulsant potencies of the enantiomers of the neurosteroids androsterone and etiocholanolone exceed those of the natural forms. Psychopharmacology (Berl) 231:3325-32
Drews, A; Mohr, F; Rizun, O et al. (2014) Structural requirements of steroidal agonists of transient receptor potential melastatin 3 (TRPM3) cation channels. Br J Pharmacol 171:1019-32
Qian, Mingxing; Krishnan, Kathiresan; Kudova, Eva et al. (2014) Neurosteroid analogues. 18. Structure-activity studies of ent-steroid potentiators of ?-aminobutyric acid type A receptors and comparison of their activities with those of alphaxalone and allopregnanolone. J Med Chem 57:171-90

Showing the most recent 10 out of 193 publications